Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchdsipsleepneuropeptides

DSIP overview revisits sleep peptide with no confirmed receptor

The 1970s-era peptide is framed as a broad neuromodulator, though its primary molecular targets remain unidentified.

PR
By Priya Raman · Science Reporter
Oct 15 14:16 ETSource: The Jewish Chronicle

The wire

  1. 01A review-style piece recaps delta sleep-inducing peptide, first identified in the 1970s, and argues current work treats it as a multifunctional signalling peptide rather than a sleep-specific agent.
  2. 02DSIP circulates widely in the research-peptide gray market for sleep complaints, so clinicians fielding questions should note the evidence base described here is mechanistic and speculative.
  3. 03The article concedes DSIP's receptor and primary molecular targets have not been conclusively established, and it cites no new human or animal data.

From the source

Delta sleep-inducing peptide (DSIP) in modern molecular science

Among the many endogenous peptides investigated over the past several decades, delta sleep-inducing peptide (DSIP) remains one of the most intriguing and enigmatic. First identified in the 1970s during investigations into naturally occurring compounds associated with sleep physiology, DSIP has continued to attract scientific interest despite persistent uncertainty surrounding its precise biologica

Read at thejc.com
PeptiPrescribed peptides from $99/moSee all →